Private Equity
Andrea Alms Video: Money In Motion 99 - Immunology Market
March 2024 - Private Equity
TRANSCRIPT Hello. My name's Andrea Alms. I'm a technology investor and financial manager and this is your money in motion On our cancer series. We take a closer look at immunotherapy. What is it? Immunotherapy is cancer treatment that boosts the body's immune system to fight the cancer. Your body's immune system detects harmful substances, so your body starts to produce antibodies and proteins to fight the infection, as opposed to traditional cancer treatment that kills both healthy and cancer cells.
According to market that U.S., the global immunotherapy market was 191 billion U.S. dollars in 2022 and estimated to grow to 674 billion in 2032. Growing at a compound average growth rate of 13.8%. A prestigious research to market was valued at 85 billion in 2021 and forecast to be 277.11 billion by 2030, growing at 12.6%. At factor R, the market was 119.4 billion in 2021 and expected to be 310 billion by 2031.
At a corporate average growth rate of 10%, averaging the averages the market size is 131.8 billion at 12.1%. Compound average growth rate triple digit market size in the billions growing at a double digit growth rate. Wow. Thank you. This is your money. Your money in motion.